Nanovi's BioXmark® is a liquid fiducial marker that changes viscosity to form a highly viscous marker with high positional stability, visible on all image modalities used in the IGRT planning and treatment phases including X-ray (kV, CT, CBCT, Flouroscopy) MRI and US. The company's products are derived from a patented biomaterial marker technology, co-invented with the Department of Health Technology at the Technical University of Denmark, DTU. Nanovi's dedication is to empower healthcare professionals with the best possible tools for the delivery of high precision radiation therapy and surgery to benefit cancer patients and to support efficiency in healthcare.